{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:02:06Z","timestamp":1790870526194,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.arbres.2026.04.007","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:46:24Z","timestamp":1777045584000},"page":"692-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings"],"prefix":"10.1016","volume":"62","author":[{"given":"Ginenus","family":"Fekadu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadesse","family":"Tolossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busha Gamachu","family":"Labata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meseret Belete","family":"Fite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tesfaye Regassa","family":"Feyissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Chai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemre","family":"Arpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firomsa","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meseret","family":"Jeldu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Kit","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2026.04.007_bib0180","unstructured":"World Health Organization. Global Tuberculosis Report 2024. https:\/\/iris.who.int\/bitstream\/handle\/10665\/379339\/9789240101531-eng.pdf?sequence=1 [accessed 15.1.25]."},{"key":"10.1016\/j.arbres.2026.04.007_bib0185","doi-asserted-by":"crossref","unstructured":"Yang H, Ruan X, Li W, Xiong J, Zheng Y. Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990\u20132021: a systematic analysis for the Global Burden of Diseases 2021 study. BMC Public Health. 24(1): 3111.","DOI":"10.1186\/s12889-024-20664-w"},{"key":"10.1016\/j.arbres.2026.04.007_bib0190","unstructured":"World Health Organization. Tuberculosis profile 2024. https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&group_code=%22global%22&entity_type=%22group%22&lan=%22EN%22 [accessed 15.1.25]."},{"key":"10.1016\/j.arbres.2026.04.007_bib0195","series-title":"WHO consolidated guidelines on tuberculosis: module 3: Diagnosis: Rapid diagnostics for tuberculosis detection","author":"World Health Organization","year":"2024"},{"issue":"4","key":"10.1016\/j.arbres.2026.04.007_bib0200","doi-asserted-by":"crossref","first-page":"e018220","DOI":"10.1136\/bmjgh-2024-018220","article-title":"Impact of all-oral bedaquiline-based shorter regimens in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"10","author":"Fekadu","year":"2025","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.arbres.2026.04.007_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.soh.2024.100072","article-title":"Global burden of HIV-negative multidrug- and extensively drug-resistant tuberculosis based on Global Burden of Disease Study 2021","volume":"3","author":"Chen","year":"2024","journal-title":"Sci One Health"},{"key":"10.1016\/j.arbres.2026.04.007_bib0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.870768","article-title":"Tuberculosis phenotypic and genotypic drug susceptibility testing and immunodiagnostics: a review","volume":"13","author":"Yusoof","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.arbres.2026.04.007_bib0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/pathogens13010027","article-title":"Rapid diagnosis of drug-resistant tuberculosis \u2013 opportunities and challenges","volume":"13","author":"Naidoo","year":"2023","journal-title":"Pathogens"},{"issue":"11","key":"10.1016\/j.arbres.2026.04.007_bib0220","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJMoa1614915","article-title":"Evaluation of a rapid molecular drug-susceptibility test for tuberculosis","volume":"377","author":"Xie","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2026.04.007_bib0225","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.2147\/IDR.S381643","article-title":"Rapid molecular assays for the diagnosis of drug-resistant tuberculosis","volume":"15","author":"Nandlal","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.arbres.2026.04.007_bib0230","article-title":"Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study","volume":"15","author":"Liu","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.arbres.2026.04.007_bib0235","series-title":"Use of targeted next-generation sequencing to detect drug-resistant tuberculosis: rapid communication","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.arbres.2026.04.007_bib0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12916-026-04693-3","article-title":"Optimizing drug-resistant tuberculosis diagnosis: cost-effectiveness of rapid molecular and phenotypic assays in South Africa","volume":"24","author":"Fekadu","year":"2026","journal-title":"BMC Med"},{"key":"10.1016\/j.arbres.2026.04.007_bib0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.103003","article-title":"Cost-effectiveness of targeted next-generation sequencing (tNGS) for detection of tuberculosis drug resistance in India, South Africa and Georgia: a modeling analysis","volume":"79","author":"Shrestha","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.arbres.2026.04.007_bib0250","article-title":"Survival analysis of risk factors for mortality in a cohort of patients with tuberculosis","volume":"2020","author":"Xie","year":"2020","journal-title":"Can Respir J"},{"key":"10.1016\/j.arbres.2026.04.007_bib0255","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment \u2013 drug-resistant tuberculosis treatment, 2022 update; 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240063129 [accessed 25.1.25]."},{"key":"10.1016\/j.arbres.2026.04.007_bib0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2021.11.1351","article-title":"CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.arbres.2026.04.007_bib0265","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.200408-1081OC","article-title":"Recurrent tuberculosis in the United States and Canada: relapse or reinfection?","volume":"170","author":"Jasmer","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.arbres.2026.04.007_bib0270","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/cid\/ciu186","article-title":"The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study","volume":"58","author":"Marx","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.arbres.2026.04.007_bib0275","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa2119430","article-title":"Bedaquiline\u2013pretomanid\u2013linezolid regimens for drug-resistant tuberculosis","volume":"387","author":"Conradie","year":"2022","journal-title":"N Engl J Med"},{"issue":"10366","key":"10.1016\/j.arbres.2026.04.007_bib0280","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0140-6736(22)02078-5","article-title":"Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial","volume":"400","author":"Goodall","year":"2022","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.arbres.2026.04.007_bib0285","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.arbres.2026.04.007_bib0290","doi-asserted-by":"crossref","first-page":"e0001337","DOI":"10.1371\/journal.pgph.0001337","article-title":"Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis","volume":"2","author":"Sweeney","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.arbres.2026.04.007_bib0295","unstructured":"World Health Organization. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27\u201329 October 2020; 2021. https:\/\/www.who.int\/publications\/i\/item\/meeting-report-of-the-who-expert-consultation-on-the-definition-of-extensively-drug-resistant-tuberculosis [accessed 25.12.23]."},{"key":"10.1016\/j.arbres.2026.04.007_bib0300","series-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.arbres.2026.04.007_bib0305","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"key":"10.1016\/j.arbres.2026.04.007_bib0310","series-title":"The world health report 2002: reducing risks, promoting healthy life","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.arbres.2026.04.007_bib0315","series-title":"GDP per capita (current US$)","author":"World Bank Open Data","year":"2024"},{"issue":"7","key":"10.1016\/j.arbres.2026.04.007_bib0320","doi-asserted-by":"crossref","first-page":"e0288605","DOI":"10.1371\/journal.pone.0288605","article-title":"Standard diagnostics with and without urine-based lipoarabinomannan testing for tuberculosis disease in HIV-infected patients in a high-burden setting \u2013 a cost-effectiveness analysis","volume":"18","author":"Fekadu","year":"2023","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.arbres.2026.04.007_bib0325","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.arbres.2026.04.007_bib0330","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.arbres.2026.04.007_bib0335","doi-asserted-by":"crossref","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Global Health"},{"key":"10.1016\/j.arbres.2026.04.007_bib0340","series-title":"Cost-effectiveness in health and medicine","author":"Neumann","year":"2016"},{"key":"10.1016\/j.arbres.2026.04.007_bib0345","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.r1983","article-title":"Priorities in addressing rifampicin-resistant TB","volume":"391","author":"Yates","year":"2025","journal-title":"BMJ"},{"issue":"10500","key":"10.1016\/j.arbres.2026.04.007_bib0350","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(25)01186-9","article-title":"Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis","volume":"406","author":"Cavalcanti","year":"2025","journal-title":"Lancet"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626001493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626001493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:38:56Z","timestamp":1790869136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289626001493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0300289626001493"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2026.04.007","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2026.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}